Jim Cramer is feeling inspired by mergers announced recently and thinks these two large players in the oil patch should get hitched.» Read More
SINGAPORE, Nov 18- U.S. crude edged lower towards $75 a barrel in early Asian trade on Tuesday, as oil prices struggle to find a floor ahead of next week's critical OPEC meeting. *Venezuela's President Nicolas Maduro said on Monday that a special global meeting was being planned "very soon" between OPEC and non- OPEC nations to discuss global oil prices.
Many traders expect stocks to rally into the year-end, but the current complacency may be signaling a late year Santa rally won't happen this year.
NEW YORK— A look at the 10 biggest volume gainers on New York Stock Exchange at the close of trading:. Actavis plc: Approximately 15,691,000 shares changed hands, a 624.3 percent increase over its 65- day average volume. The shares rose $4.17 or 1.7 percent to $247.94.
*Baker Hughes rallies, Halliburton tumbles after deal. Shares of Baker Hughes, up 8.9 percent, and Allergan, up 5.3 percent, gave the S&P 500 its biggest boost after Halliburton said it would buy Baker Hughes and Allergan agreed to be bought by Actavis. "It shows the strength of the overall market that you could have this recession news out of Japan, and yet have the...
NEW YORK— Stocks that moved substantially or traded heavily Monday on the New York Stock Exchange and the Nasdaq Stock Market:. Halliburton Co., down $5.85 to $49.23. The Botox maker is being bought by Actavis for $66 billion, which tops a bid made by Valeant Pharmaceuticals last spring.
WASHINGTON, Nov 17- Halliburton Co will have a tough time convincing U.S. regulators to approve its $35 billion deal to buy smaller rival Baker Hughes Inc but could prevail with the right divestitures, antitrust experts said Monday. Halliburton and Baker Hughes, which have already reached out to the U.S. Department of Justice, will argue that the government...
Stocks fell Monday after data had Japan unexpectedly falling into a recession.
*Brent falls toward $78 as Japanese growth stalls. NEW YORK, Nov 17- Oil prices fell and global equity markets were mixed on Monday after news that Japan unexpectedly slipped into recession in the third quarter renewed concerns about the world economy, but merger activity and comment about European stimulus capped declines. Brent oil initially fell more than $1...
M&A is alive and well in the energy sector. Here's the buzz about which companies might be next, says NYSE floor trader Kenny Polcari.
*Baker Hughes rallies, Halliburton tumbles after deal. Shares of Baker Hughes, up 10.2 percent, and Allergan, up 5.1 percent, led gains on the S&P 500 after Halliburton said it would buy Baker Hughes and Allergan agreed to be bought by Actavis. The largest percentage gainer on the S&P 500 was Baker Hughes, while the largest decliner was Halliburton, down 10.1 percent.
NEW YORK— A look at the 10 biggest percentage decliners on New York Stock Exchange at 1 p.m.:. Denbury Resources Inc. fell 12.2 percent to $9.83. William Lyon Homes fell 11.8 percent to $19.99.
NEW YORK— A look at New York Stock Exchange 10 most-active stocks at the close of trading:. Baker Hughes Inc. rose 8.9 percent to $65.23 with 52,847,300 shares traded. Bank of America Corp. fell. 3 percent to $17.09 with 41,213,800 shares traded.
Halliburton has agreed to buy rival Baker Hughes in a stock and cash deal valued at $34.6 billion. Dr. J has Baker Hughes in his trader playbook, and believes the stock goes higher from here.
*Baker Hughes rallies, Halliburton tumbles after deal. The M&A news partly offset the declines as Allergan agreed to be bought by Actavis while Halliburton said it would buy Baker Hughes. Allergan and Baker Hughes were the top point gainers on the S&P 500..
*Baker Hughes rallies on Halliburton deal; crude futures fall. *DreamWorks shares slide as Hasbro talks stall. Merger and acquisition news offset the declines as Halliburton said it would buy Baker Hughes and Allergan agreed to be bought by Actavis.
Japan's economy unexpected fall into recession increases the likelihood of demands for further stimulus.
Discussing Halliburton's roughly $34.6 billion for Baker Hughes, Michael LaMotte, Guggenheim Securities, says the deal allows both companies to get ahead of the markets on the cost curve and from a business cycle standpoint makes great sense.
*Baker Hughes rallies on Halliburton deal; crude futures fall. *DreamWorks shares slide as Hasbro talks stall. Merger and acquisition news partly offset the declines as Halliburton said it would buy Baker Hughes and Allergan is close to a buyout by Actavis.
Halliburton on Monday agreed to buy Baker Hughes in a cash and stock deal valued at $34.6 billion.
Some of the names on the move ahead of the open.